Idenix Pharmaceuticals, Inc. leads Friday small-cap pre-market volume

Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) said the FDA has essentially rejected its hepatitis C drug. Idenix is “not optimistic” about the drug’s future prospects, CEO Jean-Pierre Sommadossi said.

The following are the most actively traded companies in Friday pre-market trading among those with market capitalizations under $500 million:

For access to the full article, you must be a registered member - it's FREE.

Already a member? Please log in below